Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCZ2E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,668
Award facts
- Contract value 100% obligated
- $20,667.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $20,667.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 12, 2026, with an ultimate completion date of January 13, 2026. The contract covers the supply of Cosentyx (secukinumab) 300 mg pre-filled pens, a biologic medication used to treat inflammatory conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the contractor's capability to compete on a full and open basis for federal pharmaceutical procurement requirements.
This award represents a task order executed under AmerisourceBergen Drug Corp's parent company, Cencora, Inc.'s, comprehensive Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical. That underlying IDC, valued at up to $999,999,999.00 through December 2031, serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally. Through this arrangement, Cencora and its subsidiary supply essential medications across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, positioning the company as a critical vendor in the military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FCZ2E?
SPE2DR26FCZ2E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FCZ2E worth?
The government has obligated $20,668 on SPE2DR26FCZ2E.
Is contract SPE2DR26FCZ2E an order under another contract?
Yes. SPE2DR26FCZ2E is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCZ2E competed?
The extent of competition for SPE2DR26FCZ2E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award